Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

129.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 137.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 23,740
  • Market Cap: £137.04m
  • RiskGrade: 54

Latest ShareCast News

Cello Health sells Pulsar business to Access Intelligence

By Michele Maatouk

Date: Wednesday 02 Oct 2019

(Sharecast News) - Healthcare-focused advisory group Cello Health has sold its social media analytics software business, Pulsar, to Access Intelligence for £4.5m in shares.

Cello Health reports positive momentum as it works on US market

By Josh White

Date: Wednesday 18 Sep 2019

(Sharecast News) - Healthcare-focussed advisory firm Cello Health reported a 6.8% improvement in net revenue to £54.5m in its half-year results on Wednesday, with its like-for-like constant currency net revenue growth standing at 4.5%.

Cello Health buys US-based scientific consulting firm ISS

By Michele Maatouk

Date: Friday 16 Aug 2019

(Sharecast News) - Healthcare-led advisory group Cello Health has announced the acquisition of Innovative Science Solutions (ISS), a US-based scientific consulting firm, for up to $10.5m.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 129.00p
Change Today -2.00p
% Change -1.53 %
52 Week High 137.50
52 Week Low 101.00
Volume 23,740
Shares Issued 106.23m
Market Cap £137.04m
RiskGrade 54

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60.94% below the market average60.94% below the market average60.94% below the market average60.94% below the market average60.94% below the market average
82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average82.86% above the sector average
Price Trend
36.67% above the market average36.67% above the market average36.67% above the market average36.67% above the market average36.67% above the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average
Income
11.18% above the market average11.18% above the market average11.18% above the market average11.18% above the market average11.18% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average
Growth
31.84% below the market average31.84% below the market average31.84% below the market average31.84% below the market average31.84% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 09-Dec-2019

Time Volume / Share Price
16:13 3,000 @ 129.00p
15:47 16,000 @ 128.00p
14:46 3,000 @ 130.00p
11:47 1,740 @ 130.50p

Cello Health Key Personnel

CEO Mark Scott

Top of Page